随着众多抗精神病药物的增加,肌酸激酶对克洛扎宾有反应
Michael Dixon1, Richard Nixon2, James O'Neill3
1Dixon, BPharm (Hons) MFRPSI MCMHP, Lead Pharmacist for Medicines Information, Leeds and York Partnership NHS Foundation Trust, Pharmacy, Newsam Centre, Seacroft Hospital, Leeds, UK.
Psychopharmacology bulletin
|February 12, 2025
概括
对精神分裂症的抗精神病治疗可以导致无症状的肌酸激酶 (CK) 升高. 克洛扎宾在患有这些问题的患者中成功使用,改善了生活质量,没有副作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 抗精神病药物对于治疗精神分裂症至关重要,但可能会带来挑战.
- 在抗精神病治疗期间肌酸激酶 (CK) 的无症状升高会导致药物持续使用的不确定性.
- 神经乱性恶性综合征 (NMS) 是一种罕见但严重的与抗精神病药物相关的不良反应.
研究的目的:
- 报告一种因其他抗精神病药物的无症状肌酸激酶升高而用克洛扎宾治疗的精神分裂症病例.
- 突出克洛扎宾在患有抗精神病药物诱导的CK升高的患者中的潜在作用.
- 讨论抗精神病药物副作用的管理及其对治疗坚持的影响.
主要方法:
- 一个病例报告详细介绍了一名患有精神分裂症的患者,他经历了反复出现的无症状肌酸激酶 (CK) 升高.
- 对抗精神病治疗试验及其相关的CK水平的审查.
- 客观测量生活质量得分和评估身体健康后果.
主要成果:
- 患者在使用各种抗精神病药物时,肌酸激酶 (CK) 水平出现了多次无症状的增加,需要停止服用这些药物.
- 克洛扎治疗开始并被很好地容忍,没有报告身体健康问题.
- 客观测量表明,在克洛沙平治疗期间,生活质量有所改善.
结论:
- 克洛扎宾可以成为精神分裂症患者的可行和有效的治疗选择,这些患者在使用其他抗精神病药物时发展出无症状的肌酸激酶升高.
- 建议在抗精神病治疗期间面临CK水平升高或神经乱性恶性综合征 (NMS) 病史时考虑使用克洛扎宾.
- 这一案例强调了个性化治疗方法在治疗精神分裂症及其相关药物副作用方面的重要性.
相关概念视频
Psychosis: Goals of Pharmacotherapy
102
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
102
Psychosis and Antipsychotic Drugs: Overview
171
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
171
Antipsychotic Drugs: Therapeutic Uses and Side Effects
118
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
118
Antipsychotic Drugs: Typical and Atypical Agents
151
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
151
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37


